Valuation: Sugentech Inc.

Capitalization 81.49B 56.63M 53.91M 50.85M 44.91M 80.23M 4.91B 89.03M 605M 224M 2.05B 212M 208M 8.61B P/E ratio 2022
6.73x
P/E ratio 2023 -6.85x
Enterprise value 29.98B 20.83M 19.83M 18.71M 16.52M 29.52M 1.8B 32.75M 223M 82.51M 755M 78.09M 76.52M 3.17B EV / Sales 2022
0.71x
EV / Sales 2023 9.38x
Free-Float
76.65%
Yield 2022
1.48%
Yield 2023 -
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.82%
1 week-7.50%
Current month-10.30%
1 month-28.50%
3 months+11.49%
6 months-33.63%
Current year+11.07%
More quotes
1 week
5 890.00
Extreme 5890
6 520.00
1 month
5 890.00
Extreme 5890
8 700.00
Current year
5 330.00
Extreme 5330
10 300.00
1 year
4 700.00
Extreme 4700
11 500.00
3 years
4 700.00
Extreme 4700
21 550.00
5 years
4 700.00
Extreme 4700
65 800.00
10 years
4 510.00
Extreme 4510
65 800.00
More quotes
Director TitleAgeSince
Chief Tech/Sci/R&D Officer 58 2017-09-25
Chief Executive Officer 60 2017-09-25
Director of Finance/CFO 54 2022-03-30
Manager TitleAgeSince
Director/Board Member 60 2017-09-25
Director/Board Member 58 2017-09-25
Director/Board Member 49 2022-03-30
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-1.82%-7.50%-12.56%-71.94% 62.64M
+0.53%+1.06%+12.97%+13.31% 14.04B
-2.49%+3.74%-15.58%+62.92% 6.67B
+2.69%+8.66%+119.14%-30.97% 5.8B
-1.71%-8.92%+43.34%+184.11% 5.7B
+0.35%+0.40%+16.10%-15.87% 5.59B
+3.12%+3.68%-22.92%-15.63% 3.19B
-0.95%+6.53%+6.40%-27.93% 2.69B
+0.49%-3.55%+10.73%-43.94% 2.58B
+2.73%+10.96%+13.26%-30.01% 1.75B
Average +0.32%-1.53%+17.09%+2.40% 4.81B
Weighted average by Cap. +0.27%-1.44%+22.90%+22.71%
See all sector performances

Financials

2022 2023
Net sales 101B 70.46M 67.08M 63.27M 55.88M 99.83M 6.1B 111M 753M 279M 2.55B 264M 259M 10.71B 7.13B 4.96M 4.72M 4.45M 3.93M 7.02M 429M 7.79M 52.99M 19.63M 180M 18.58M 18.2M 754M
Net income 26.72B 18.56M 17.67M 16.67M 14.72M 26.3M 1.61B 29.19M 198M 73.53M 672M 69.59M 68.19M 2.82B -17.24B -11.98M -11.4M -10.76M -9.5M -16.97M -1.04B -18.83M -128M -47.44M -434M -44.9M -44M -1.82B
Net Debt -93.57B -65.02M -61.9M -58.38M -51.56M -92.12M -5.63B -102M -695M -258M -2.36B -244M -239M -9.89B -51.51B -35.8M -34.08M -32.14M -28.39M -50.72M -3.1B -56.28M -383M -142M -1.3B -134M -131M -5.44B
More financial data * Estimated data
Logo Sugentech Inc.
Sugentech Incorporate is a Korea-based company mainly engaged in the production and sale of in-vitro diagnostic test reagents. The Company is involved in the manufacturing and sale of in vitro diagnostic test reagents, point-of-care testing (POCT) products, folic acid products under the name of SOLGAR, as well as molecular diagnostic reagents. The in vitro diagnostic test reagents are for personal use and are sold under the name SUREARLY. The POCT products are for professional use and are sold under the name INCLIX. In addition, the Company is engaged in therapeutic drug monitoring, as well as drug analysis method development. The Company distributes its products within the domestic market and to overseas markets, including Indonesia.
Employees
145
More about the company
Date Price Change Volume
25-02-14 5,800.00 -2.03% 125,350
25-02-13 5,920.00 -1.82% 181,768
25-02-12 6,030.00 -3.52% 263,021
25-02-11 6,250.00 +1.13% 558,642
25-02-10 6,180.00 -0.32% 196,193

End-of-day quote Korea S.E., February 12, 2025

More quotes
  1. Stock Market
  2. Equities
  3. A253840 Stock